Bio-Rad Laboratories Gross Profit 2010-2022 | BIO.B

Bio-Rad Laboratories annual/quarterly gross profit history and growth rate from 2010 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Bio-Rad Laboratories gross profit for the quarter ending September 30, 2022 was $0.374B, a 14.55% decline year-over-year.
  • Bio-Rad Laboratories gross profit for the twelve months ending September 30, 2022 was $1.574B, a 7.38% decline year-over-year.
  • Bio-Rad Laboratories annual gross profit for 2021 was $1.641B, a 14.11% increase from 2020.
  • Bio-Rad Laboratories annual gross profit for 2020 was $1.438B, a 14.39% increase from 2019.
  • Bio-Rad Laboratories annual gross profit for 2019 was $1.257B, a 2.77% increase from 2018.
Bio-Rad Laboratories Annual Gross Profit
(Millions of US $)
2021 $1,641
2020 $1,438
2019 $1,257
2018 $1,223
2017 $1,188
2016 $1,138
2015 $1,122
2014 $1,179
2013 $1,178
2012 $1,155
2011 $1,179
2010 $1,091
2009 $1,000
Bio-Rad Laboratories Quarterly Gross Profit
(Millions of US $)
2022-09-30 $374
2022-06-30 $396
2022-03-31 $404
2021-12-31 $401
2021-09-30 $437
2021-06-30 $402
2021-03-31 $401
2020-12-31 $460
2020-09-30 $367
2020-06-30 $293
2020-03-31 $317
2019-12-31 $330
2019-09-30 $307
2019-06-30 $308
2019-03-31 $312
2018-12-31 $333
2018-09-30 $287
2018-06-30 $302
2018-03-31 $302
2017-12-31 $345
2017-09-30 $299
2017-06-30 $273
2017-03-31 $270
2016-12-31 $315
2016-09-30 $279
2016-06-30 $280
2016-03-31 $264
2015-12-31 $309
2015-09-30 $263
2015-06-30 $280
2015-03-31 $270
2014-12-31 $317
2014-09-30 $289
2014-06-30 $297
2014-03-31 $275
2013-12-31 $323
2013-09-30 $284
2013-06-30 $300
2013-03-31 $271
2012-12-31 $315
2012-09-30 $274
2012-06-30 $288
2012-03-31 $279
2011-12-31 $312
2011-09-30 $296
2011-06-30 $293
2011-03-31 $278
2010-12-31 $300
2010-09-30 $266
2010-06-30 $268
2010-03-31 $257
2009-12-31 $268
2009-09-30 $261
2009-06-30 $242
2009-03-31 $229
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.069B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $168.264B 10.27
GSK (GSK) United Kingdom $68.657B 8.61
QIAGEN (QGEN) Netherlands $11.145B 19.02
Ginkgo Bioworks Holdings (DNA) United States $3.570B 0.00
Myovant Sciences (MYOV) United Kingdom $2.594B 0.00
Arcus Biosciences (RCUS) United States $2.073B 31.12
Biohaven (BHVN) United States $0.982B 0.00
Emergent Biosolutions (EBS) United States $0.579B 4.55
Zymeworks (ZYME) Canada $0.493B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.261B 0.00
Enzo Biochem (ENZ) United States $0.094B 0.00
SQZ Biotechnologies (SQZ) United States $0.078B 0.00
Gelesis Holdings (GLS) United States $0.028B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00